Epistemonikos | Repository

Recommendation

Strongly Recommended In Favor

Strong recommendation

Certainty of evidence

Moderate

Use of darunavir/ritonavir and other protease inhibitors in HIV treatment. Darunavir/ritonavir (DRV/r) is the preferred boosted protease inhibitor option for antiretroviral treatment.

Year: 2025
Institution: World health organization
Guideline: Not available